NCT00113295View on ClinicalTrials.gov

Combination of Paroxetine CR and Quetiapine for the Treatment of Refractory Generalized Anxiety Disorder

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

February 28, 2007

Study Completion Date

November 30, 2007

Conditions
Anxiety Disorder
Interventions
DRUG

Continued Paroxetine CR

DRUG

Quetiapine

DRUG

Placebo

Trial Locations (2)

27710

Duke University Medical Center, Durham

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT00113295 - Combination of Paroxetine CR and Quetiapine for the Treatment of Refractory Generalized Anxiety Disorder | Biotech Hunter | Biotech Hunter